Article metrics

Download PDFPDF

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

 

Online download statistics by month:

Online download statistics by month: March 2020 to August 2021

AbstractFullPdf
Mar 2020777712
Apr 202016841661529
May 2020874862334
Jun 2020667660305
Jul 2020411398185
Aug 2020240224108
Sep 2020253244156
Oct 2020182158198
Nov 2020206196129
Dec 2020217209107
Jan 2021335327163
Feb 2021348345157
Mar 2021416401162
Apr 202120019698
May 2021194179106
Jun 2021184179125
Jul 202111911874
Aug 2021200188130
Total680766223078